Immuno-Oncology
Working toward further advances in immuno-oncology
Immuno-oncology has emerged as a promising approach to cancer treatment, using the body's immune system to fight cancer. Standard BioTools™ provides the tools and services to support advances in immuno-oncology research, including cell profiling and biomarker identification.
Our optimized, flexible and efficient assays are designed to meet the rigorous demands of translational and clinical research programs.
Immuno-Oncology with Imaging Mass Cytometry
Using high-multiplex imaging to investigate the spatial biology of the complex tumor microenvironment.
Immuno-Oncology with Mass Cytometry
The use of CAR cells as therapeutic agents in cancer is expanding at a rapid pace. Investigators are taking innovative approaches to address these challenges.
Immuno-Oncology with Microfluidics
A reliable, sensitive and cost-effective toolset for identifying gene expression signatures from immune and cancer cells.
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2024 Standard BioTools Inc. All rights reserved.